Որոնման արդյունքները - Ray D. Page
- Ցուցադրվում են 1 - 10 արդյունքները 10
-
1
Opioids and Cancer Pain: Patients’ Needs and Access Challenges Ray D. Page, Elizabeth Blanchard
Հրապարակվել է 2019Editorial -
2
-
3
Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer Mark A. Socinski, Corey J. Langer, Isamu Okamoto, Jeremy K. Hon, Vera Hirsh, Shaker R. Dakhil, Ray D. Page, James Orsini, H. Zhang, Markus F. Renschler
Հրապարակվել է 2012Artigo -
4
Multicenter Phase II Trial of ABI-007, an Albumin-Bound Paclitaxel, in Women With Metastatic Breast Cancer Nuhad K. Ibrahim, Brian L. Samuels, Ray D. Page, Dinesh Chandra Doval, Kirtikumar M. Patel, Sujaya Rao, Madhavan Krishnan Nair, Paul Bhar, Neil Desai, Gabriel N. Hortobágyi
Հրապարակվել է 2005Artigo -
5
Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer Natasha B. Leighl, Ray D. Page, Victoria M. Raymond, Davey B. Daniel, Stephen G. Divers, Karen L. Reckamp, Miguel A. Villalona‐Calero, Daniel Dix, Justin I. Odegaard, Richard B. Lanman, Vassiliki A. Papadimitrakopoulou
Հրապարակվել է 2019Artigo -
6
Telehealth in Oncology: ASCO Standards and Practice Recommendations Robin Zoň, Erin B. Kennedy, Kerin B. Adelson, Sibel Blau, N Dickson, David Gill, Nicole Laferriere, Ana María López, Therese M. Mulvey, Debra A. Patt, Todd Pickard, Terry Purdom, Trevor J. Royce, Ashley Sumrall, Ray D. Page
Հրապարակվել է 2021Revisão -
7
P3.02c-026 Is Nivolumab Safe and Effective in Elderly and PS2 Patients with Non-Small Cell Lung Cancer (NSCLC)? Results of CheckMate 153 David R. Spigel, Lee S. Schwartzberg, David Waterhouse, Jason C. Chandler, Maen Hussein, Robert M. Jotte, Edward J. Stepanski, Michael McCleod, Ray D. Page, Rohini Sen, Jeffrey G. McDonald, Kelly L. Bennett, Beata Korytowsky, Nivedita Aanur, Craig H. Reynolds
Հրապարակվել է 2017Artigo -
8
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC Jennifer J. Knox, Carlos H. Barrios, T.M. Kim, Thomas M. Cosgriff, Vichien Srimuninnimit, K. Pittman, Roberto Sabbatini, Sun Young Rha, Thomas W. Flaig, Ray D. Page, J. Thaddeus Beck, Florence Cheung, S. Yadav, Poulam M. Patel, Lionnel Geoffrois, Julie Niolat, Noah Berkowitz, Mahtab Marker, Dehui Chen, Robert J. Motzer
Հրապարակվել է 2017Artigo -
9
Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Re... Robert J. Motzer, Carlos H. Barrios, Tae Min Kim, S. Falcon, Thomas M. Cosgriff, W G Harker, Vichien Srimuninnimit, Ken Pittman, Roberto Sabbatini, Sun Young Rha, Thomas W. Flaig, Ray D. Page, Sevil Bavbek, J. Thaddeus Beck, Poulam M. Patel, F.Y. Cheung, Sunil Kumar Yadav, Edward Schiff, Xufang Wang, Julie Niolat, Dalila Sellami, Oezlem Anak, Jennifer J. Knox
Հրապարակվել է 2014Artigo -
10
PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer Hui Yu, Cory Batenchuk, A. Badzio, Theresa A. Boyle, Piotr Czapiewski, Daniel C. Chan, Xian Lu, Dexiang Gao, Kim Ellison, Ashley Kowalewski, Christopher J. Rivard, Rafał Dziadziuszko, Caicun Zhou, Maen Hussein, Donald Richards, Sharon Wilks, Marc Monte, William J. Edenfield, Jerome H. Goldschmidt, Ray D. Page, Brian Ulrich, David Waterhouse, Sandra Close, Jacek Jassem, Kimary Kulig, Fred R. Hirsch
Հրապարակվել է 2016Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Medicine
Internal medicine
Cancer
Gastroenterology
Lung cancer
Oncology
Chemotherapy
Confidence interval
Hazard ratio
Surgery
Biology
Clinical endpoint
Everolimus
Family medicine
Genetics
Law
Neutropenia
Pathology
Political science
Randomized controlled trial
Renal cell carcinoma
Sunitinib
Urology
Adverse effect
Anemia
Bioinformatics
Breast cancer
Cancer research
Carboplatin
Carcinoembryonic antigen